Panel Member	Clinical Research Support	Advisory Boards, Speakers Bureau, Expert Witness, or Consultant	Patent, Equity, or Royalty	Other	Date Completed
Wallace Akerley, MD	Genentech, Inc.; OSI Pharmaceuticals, Inc.	Genentech, Inc.	None	None	9/28/2009
Gerold Bepler, MD, PhD	Genzyme Corporation	Eli Lilly and Company; OSI Pharmaceuticals, Inc.; GenMab	Genzyme Corporation	Eli Lilly and Company; sanofi-aventis U.S.	12/15/2008
Matthew G. Blum, MD	None	None	None	None	7/17/2009
Andrew Chang, MD	None	None	None	None	9/28/2009
Richard T. Cheney, MD	None	None	None	None	12/15/2008
Lucian R. Chirieac, MD	None	None	None	None	10/2/2009
Thomas A. D'Amico, MD	None	Covidien AG; Scanlan	None	None	7/1/2009
Todd L. Demmy, MD	None	Covidien AG	None	None	7/13/2009
David S. Ettinger, MD	None	AstraZeneca Pharmaceuticals LP; Bristol-Myers Squibb Company; Eli Lilly and Company; Genentech, Inc.; GlaxoSmithKline	None	None	7/6/2009
Lauren Gallagher, PhD	None	None	None	None	8/28/2009
Ramaswamy Govindan, MD	None	Bristol-Myers Squibb Company; Eli Lilly and Company; Genentech, Inc.; Pfizer Inc.; sanofi-aventis U.S.	None	None	10/14/2009
Frederic W. Grannis, MD	GlaxoSmithKline	Steven Phillips (sphillips@lpklaw.com)	None	Medtronic, Inc.	7/14/2009
Kristina M Gregory, RN, MSN, OCN	None	None	None	None	8/21/2009
Miranda Hughes, PhD	None	None	Myriad Genetic Laboratories, Inc.; Affymetrix; Qiagen NV	None	7/21/2009
Thierry M. Jahan, MD	Eli Lilly and Company; Genentech, Inc.; Morphotek Inc.	Poniard Pharmaceuticals	None	None	12/15/2008
Mohammad Jahanzeb, MD, FACP	Genentech, Inc.; Oxigene; Pfizer Inc.	Abraxis Bioscience, Inc.; AstraZeneca Pharmaceuticals LP; Eli Lilly and Company; Genentech, Inc.; GlaxoSmithKline; Pfizer Inc.; sanofi-aventis U.S.	None	None	10/29/2009
David H. Johnson, MD	Merck & Co., Inc.; Theradex (Idera)	None	None	None	9/29/2009
Anne Kessinger, MD	Pharmacyclics; sanofi-aventis U.S.	None	None	None	5/19/2009
Ritsuko Komaki, MD	Pfizer Inc.	None	None	None	10/2/2009
Feng-Ming (Spring) Kong, MD, PhD, MPH	None	None	None	None	8/17/2009
Mark G. Kris, MD	None	AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim GmbH; Daiichi- Sankyo Co.; GlaxoSmithKline; Merck & Co., Inc.; Morphotek Inc.; National Cancer Institute; Novartis Pharmaceuticals Corporation; Biodesix; Prometheus; Syndax; Pfizer Inc.; Schering-Plough Corporation	None	None	10/2/2009
Quynh-Thu Le, MD	Amgen Inc.; GlaxoSmithKline; National Cancer Institute; Varian Medical Systems, Inc.	None	None	None	7/2/2009
Inga T. Lennes, MD	None	None	None	None	7/1/2009
Renato Martins, MD, MPH	Amgen Inc.; Eli Lilly and Company; Genentech, Inc.; Novartis Pharmaceuticals Corporation; infinity Pharmaceuticals, Inc; Pfizer Inc.	Eli Lilly and Company; Genentech, Inc.	None	None	9/30/2009
Joan S McClure, MS	None	None	None	None	9/28/2009
Janis O'Malley, MD					Pending
Raymond U. Osarogiagbon, MD, FACP	Bristol-Myers Squibb Company; Eli Lilly and Company; OSI Pharmaceuticals, Inc.; sanofi-aventis U.S.	Genentech, Inc.; OSI Pharmaceuticals, Inc.; sanofi-aventis U.S.; UnitedHealthcare	None	None	10/1/2009
Gregory A. Otterson, MD	Abraxis Oncology; Boehringer Ingelheim GmbH; Eli Lilly and Company; Genentech, Inc.; Pharmacyclics; sanofi-aventis U.S.	Eli Lilly and Company; Genentech, Inc.	None	None	10/1/2009
Jyoti D. Patel, MD	Eli Lilly and Company; Genentech, Inc.	Eli Lilly and Company; Genentech, Inc.	None	None	7/6/2009
Katherine M Pisters, MD	None	None	None	None	7/1/2009
Karen Reckamp, MD, MS	Amgen Inc.; GlaxoSmithKline; OSI Pharmaceuticals, Inc.; Tragara Pharmaceuticals; Pfizer Inc.; Wyeth Pharmaceuticals	Amgen Inc.; Eli Lilly and Company; Genentech, Inc.; Tragara Pharmaceuticals	None	None	7/1/2009
Eric Rohren, MD, PhD	None	None	None	None	7/1/2009
George R. Simon, MD, FACP, FCCP	None	None	None	None	7/10/2009
Scott Swanson, MD	None	Covidien AG; Ethicon, Inc.	None	None	8/26/2009
Douglas E. Wood, MD	None	None	None	None	9/28/2009
Stephen C. Yang, MD	None	None	None	None	12/15/2008

NCCN Website Supporters